Zepp Health Corporation

NYSE:ZEPP Stock Report

Market Cap: US$48.9m

Zepp Health Future Growth

Future criteria checks 0/6

Zepp Health is forecast to grow earnings and revenue by 76.4% and 1.6% per annum respectively while EPS is expected to grow by 124.9% per annum.

Key information

76.4%

Earnings growth rate

124.9%

EPS growth rate

Electronic earnings growth17.3%
Revenue growth rate1.6%
Future return on equityn/a
Analyst coverage

Low

Last updated27 Aug 2024

Recent future growth updates

Recent updates

Zepp Health Corporation (NYSE:ZEPP) Stock Catapults 26% Though Its Price And Business Still Lag The Industry

Aug 20
Zepp Health Corporation (NYSE:ZEPP) Stock Catapults 26% Though Its Price And Business Still Lag The Industry

Calculating The Intrinsic Value Of Zepp Health Corporation (NYSE:ZEPP)

Aug 03
Calculating The Intrinsic Value Of Zepp Health Corporation (NYSE:ZEPP)

Zepp Health Corporation (NYSE:ZEPP) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

Apr 17
Zepp Health Corporation (NYSE:ZEPP) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

Zepp Health Corporation's (NYSE:ZEPP) Price Is Right But Growth Is Lacking After Shares Rocket 30%

Dec 23
Zepp Health Corporation's (NYSE:ZEPP) Price Is Right But Growth Is Lacking After Shares Rocket 30%

Zepp Leaves Investors Guessing With Return To Profits, Tumbling Own-Brand Sales

Nov 24

Can Zepp Health Find Its Way Back Up?

Jul 31

Zepp Health Non-GAAP EPADS of -$0.23, revenue of $165.5M

Aug 25

What Does Zepp Health Corporation's (NYSE:ZEPP) Share Price Indicate?

Aug 12
What Does Zepp Health Corporation's (NYSE:ZEPP) Share Price Indicate?

Zepp: Speculative, But With Potentially Great Rewards

Jun 08

What Does Zepp Health Corporation's (NYSE:ZEPP) Share Price Indicate?

Mar 16
What Does Zepp Health Corporation's (NYSE:ZEPP) Share Price Indicate?

Is Zepp Health Corporation (NYSE:ZEPP) Worth US$3.8 Based On Its Intrinsic Value?

Feb 23
Is Zepp Health Corporation (NYSE:ZEPP) Worth US$3.8 Based On Its Intrinsic Value?

Zepp Health Stuck In Rut As Global Chip Shortage, Covid Weigh

Jan 06

When Should You Buy Zepp Health Corporation (NYSE:ZEPP)?

Dec 15
When Should You Buy Zepp Health Corporation (NYSE:ZEPP)?

Investors Will Want Zepp Health's (NYSE:ZEPP) Growth In ROCE To Persist

Oct 28
Investors Will Want Zepp Health's (NYSE:ZEPP) Growth In ROCE To Persist

Globally Minded Zepp Raises Eyebrows With New Ultra-Long Life Smartwatch

Oct 15

Zepp: A Solid International Diversification Play

Oct 03

Is It Too Late To Consider Buying Zepp Health Corporation (NYSE:ZEPP)?

Sep 13
Is It Too Late To Consider Buying Zepp Health Corporation (NYSE:ZEPP)?

Zepp Health: Taking Over The Smart Health Wearables Market

Jul 14

We Think Zepp Health (NYSE:ZEPP) Can Stay On Top Of Its Debt

Jul 07
We Think Zepp Health (NYSE:ZEPP) Can Stay On Top Of Its Debt

Returns On Capital Are Showing Encouraging Signs At Zepp Health (NYSE:ZEPP)

May 31
Returns On Capital Are Showing Encouraging Signs At Zepp Health (NYSE:ZEPP)

Earnings and Revenue Growth Forecasts

NYSE:ZEPP - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2025234-45N/A1
12/31/2024197-34-2N/A1
6/30/2024237-25N/AN/AN/A
3/31/2024296-25N/AN/AN/A
12/31/2023352-304042N/A
9/30/2023406-38N/AN/AN/A
6/30/2023492-41N/AN/AN/A
3/31/2023587-49N/AN/AN/A
12/31/2022601-42-116-114N/A
9/30/2022665-25N/AN/AN/A
6/30/2022766-16N/AN/AN/A
3/31/202292414N/AN/AN/A
12/31/202198322-45-37N/A
9/30/20211,01734N/AN/AN/A
6/30/20211,11438N/AN/AN/A
3/31/202199126N/AN/AN/A
12/31/2020986351124N/A
9/30/202096847N/AN/AN/A
6/30/202087763N/AN/AN/A
3/31/202086173N/AN/AN/A
12/31/2019835825561N/A
9/30/201968967N/AN/AN/A
6/30/201960357N/AN/AN/A
3/31/201957558N/AN/AN/A
12/31/20185301693103N/A
9/30/20184624N/AN/AN/A
6/30/2018389-10N/AN/AN/A
3/31/2018367-22N/AN/AN/A
12/31/20173157N/A37N/A
9/30/20172878N/A44N/A
12/31/2016224-2N/A2N/A
12/31/2015138-9N/A-1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ZEPP is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: ZEPP is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: ZEPP is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: ZEPP's revenue (1.6% per year) is forecast to grow slower than the US market (8.9% per year).

High Growth Revenue: ZEPP's revenue (1.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if ZEPP's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y